DP

Diadema Partners Portfolio holdings

AUM $161M
This Quarter Return
+0.4%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$161M
AUM Growth
+$35.7M
Cap. Flow
+$39.8M
Cap. Flow %
24.76%
Top 10 Hldgs %
70.2%
Holding
94
New
17
Increased
16
Reduced
11
Closed
14
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ANAB icon
51
AnaptysBio
ANAB
$590M
0
ASND icon
52
Ascendis Pharma
ASND
$12B
-8,321
Closed -$1.3M
BBIO icon
53
BridgeBio Pharma
BBIO
$9.91B
0
BHVN icon
54
Biohaven
BHVN
$1.7B
0
BMEA icon
55
Biomea Fusion
BMEA
$109M
0
CADL icon
56
Candel Therapeutics
CADL
$268M
-25,045
Closed -$142K
CAPR icon
57
Capricor Therapeutics
CAPR
$272M
0
CMPX icon
58
Compass Therapeutics
CMPX
$466M
0
CNTA
59
Centessa Pharmaceuticals
CNTA
$2.12B
-164,048
Closed -$2.36M
CORT icon
60
Corcept Therapeutics
CORT
$7.31B
0
CRDF icon
61
Cardiff Oncology
CRDF
$142M
0
CRSP icon
62
CRISPR Therapeutics
CRSP
$4.8B
0
CYTK icon
63
Cytokinetics
CYTK
$5.95B
-20,000
Closed -$804K
EOLS icon
64
Evolus
EOLS
$486M
0
EWTX icon
65
Edgewise Therapeutics
EWTX
$1.54B
0
FOLD icon
66
Amicus Therapeutics
FOLD
$2.47B
0
GOSS icon
67
Gossamer Bio
GOSS
$571M
-269,589
Closed -$297K
IMUX icon
68
Immunic
IMUX
$76M
0
KALV icon
69
KalVista Pharmaceuticals
KALV
$765M
-135,509
Closed -$1.56M
KROS icon
70
Keros Therapeutics
KROS
$632M
0
MLTX icon
71
MoonLake Immunotherapeutics
MLTX
$3.79B
0
MNKD icon
72
MannKind Corp
MNKD
$1.64B
0
MREO
73
Mereo BioPharma
MREO
$275M
-492,215
Closed -$169K
MRNA icon
74
Moderna
MRNA
$9.45B
0
NKTR icon
75
Nektar Therapeutics
NKTR
$684M
0